David L. Clark

2.3k total citations · 1 hit paper
68 papers, 1.8k citations indexed

About

David L. Clark is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David L. Clark has authored 68 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Neurology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in David L. Clark's work include Vestibular and auditory disorders (9 papers), Ocular Surface and Contact Lens (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). David L. Clark is often cited by papers focused on Vestibular and auditory disorders (9 papers), Ocular Surface and Contact Lens (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). David L. Clark collaborates with scholars based in United States, United Kingdom and Slovakia. David L. Clark's co-authors include Francis J. White, Trevor Sharp, David G. Grahame‐Smith, Phillip W. Taylor, Oren Hasson, James C. Gillingham, Todd C. Brady, Mario F. Mendez, Nashaat N. Boutros and John D. Sheppard and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

David L. Clark

61 papers receiving 1.7k citations

Hit Papers

Review: D1 dopamine receptor—the search for a function: A... 1987 2026 2000 2013 1987 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
    1987 601 citations David L. Clark et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Clark United States 21 803 493 224 224 176 68 1.8k
Sonja Blum United States 16 494 0.6× 295 0.6× 376 1.7× 203 0.9× 121 0.7× 22 1.3k
Reiko Hara Japan 25 882 1.1× 671 1.4× 168 0.8× 281 1.3× 80 0.5× 59 2.0k
P Simon France 15 535 0.7× 471 1.0× 338 1.5× 121 0.5× 74 0.4× 46 1.9k
Deborah Commins United States 28 783 1.0× 388 0.8× 129 0.6× 71 0.3× 239 1.4× 54 2.4k
Zofia Żukowska United States 27 1.4k 1.7× 811 1.6× 156 0.7× 344 1.5× 99 0.6× 50 3.6k
Michael D. Hayward United States 20 904 1.1× 902 1.8× 195 0.9× 60 0.3× 60 0.3× 40 2.3k
Cristovam Wanderley Picanço Diniz Brazil 26 606 0.8× 619 1.3× 468 2.1× 114 0.5× 106 0.6× 118 2.0k
Y. Takeuchi Japan 19 712 0.9× 336 0.7× 156 0.7× 53 0.2× 111 0.6× 65 1.3k
Justyna R. Sarna Canada 21 434 0.5× 391 0.8× 280 1.3× 179 0.8× 372 2.1× 45 1.6k
Michael E. Selzer United States 35 2.1k 2.6× 1.1k 2.2× 203 0.9× 241 1.1× 166 0.9× 129 3.6k

Countries citing papers authored by David L. Clark

Since Specialization
Citations

This map shows the geographic impact of David L. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Clark more than expected).

Fields of papers citing papers by David L. Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Clark. The network helps show where David L. Clark may publish in the future.

Co-authorship network of co-authors of David L. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Clark. A scholar is included among the top collaborators of David L. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Clark. David L. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clark, David L.. (2022). Rethinking Heart Failure: Patient Classification and Treatment. The American Journal of Managed Care. 28(Suppl 14). S255–S267. 4 indexed citations
2.
Clark, David L., Paul Karpecki, Anne Marie Salapatek, John D. Sheppard, & Todd C. Brady. (2022). Reproxalap Improves Signs and Symptoms of Allergic Conjunctivitis in an Allergen Chamber: A Real-World Model of Allergen Exposure. SHILAP Revista de lepidopterología. 11 indexed citations
3.
Moss, Nicholas, et al.. (2022). Unique Cell Subpopulations and Disease Progression Markers in Canines with Atopic Dermatitis. The Journal of Immunology. 209(7). 1379–1388. 6 indexed citations
4.
Clark, David L., John D. Sheppard, & Todd C. Brady. (2021). A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease. Journal of Ocular Pharmacology and Therapeutics. 37(4). 193–199. 24 indexed citations
5.
Clark, David L., et al.. (2021). Clinically Relevant Activity of the Novel RASP Inhibitor Reproxalap in Allergic Conjunctivitis: The Phase 3 ALLEVIATE Trial. American Journal of Ophthalmology. 230. 60–67. 18 indexed citations
6.
Clark, David L., Joseph Tauber, John D. Sheppard, & Todd C. Brady. (2021). Early Onset and Broad Activity of Reproxalap in a Randomized, Double-Masked, Vehicle-Controlled Phase 2b Trial in Dry Eye Disease. American Journal of Ophthalmology. 226. 22–31. 22 indexed citations
7.
Clark, David L., et al.. (2021). A double-blinded placebo-controlled evaluation of adipose-derived mesenchymal stem cells in treatment of canine atopic dermatitis. Veterinary Research Communications. 46(1). 251–260. 9 indexed citations
8.
Mandell, Kenneth J., David L. Clark, David Chu, et al.. (2020). Randomized Phase 2 Trial of Reproxalap, a Novel Reactive Aldehyde Species Inhibitor, in Patients with Noninfectious Anterior Uveitis: Model for Corticosteroid Replacement. Journal of Ocular Pharmacology and Therapeutics. 36(10). 732–739. 16 indexed citations
9.
Gomes, Paul J, Todd C. Brady, David Hollander, & David L. Clark. (2018). A Randomized, Multi-Center, Double-Masked, Vehicle-Controlled, Parallel-Group Phase 2b Allergic Conjunctivitis Clinical Trial of Topical Ocular ADX-102, a Novel Aldehyde Sequestering Agent. Investigative Ophthalmology & Visual Science. 59(9). 5571–5571. 1 indexed citations
10.
Clark, David L.. (2015). The Global Financial Crisis and Austerity: A Basic Introduction. Project Muse (Johns Hopkins University). 2 indexed citations
11.
Neethling, JB, et al.. (2013). Striking the Balance between Nutrient Removal, Greenhouse Gas Emissions, Receiving Water Quality, and Costs. Water Environment Research. 85(12). 2307–2316. 23 indexed citations
12.
Kangarlu, Allahyar, et al.. (2004). Limits of 8‐Tesla magnetic resonance imaging spatial resolution of the deoxygenated cerebral microvasculature. Journal of Magnetic Resonance Imaging. 19(3). 303–307. 13 indexed citations
13.
Clark, David L. & Robert L. Ayres. (1998). Capitalism, Industrialisation and Development: The Dependency Paradigm Revisited. Capital & Class.
14.
Clark, David L.. (1997). The Mormons of the Wisconsin Territory: 1835-1848. BYU studies quarterly. 37(2). 4. 1 indexed citations
15.
Clark, David L., et al.. (1993). Subtle variations in living conditions influence behavioural response to d-amphetamine. Neuroreport. 4(8). 1059–1062. 6 indexed citations
16.
Clark, David L.. (1990). Monstrous Reading: The Martyrology After de Man. Studies in Canadian Literature. 15(2).
17.
Clark, David L., et al.. (1989). Effects of Rocking on Neuromuscular Development in the Premature. Neonatology. 56(6). 306–314. 14 indexed citations
18.
Hjorth, Stephan, David L. Clark, & Arvid Carlsson. (1988). Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation. European Journal of Pharmacology. 152(3). 207–215. 17 indexed citations
19.
Vaziri, N.D., et al.. (1978). Dialysability of Theophylline. PubMed. 2(3). 243–249. 3 indexed citations
20.
Kantner, Robert M., et al.. (1976). Effects of Vestibular Stimulation on Nystagmus Response and Motor Performance in the Developmentally Delayed Infant. Physical Therapy. 56(4). 414–421. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonja Blum Breakdown of academic impact, for papers by Reiko Hara Breakdown of academic impact, for papers by P Simon Breakdown of academic impact, for papers by Deborah Commins Breakdown of academic impact, for papers by Zofia Żukowska Breakdown of academic impact, for papers by Michael D. Hayward Breakdown of academic impact, for papers by Cristovam Wanderley Picanço Diniz Breakdown of academic impact, for papers by Y. Takeuchi Breakdown of academic impact, for papers by Justyna R. Sarna Breakdown of academic impact, for papers by Michael E. Selzer
Rankless by CCL
2026